These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
478 related articles for article (PubMed ID: 27291902)
1. Dopamine Targeting Drugs for the Treatment of Schizophrenia: Past, Present and Future. Li P; Snyder GL; Vanover KE Curr Top Med Chem; 2016; 16(29):3385-3403. PubMed ID: 27291902 [TBL] [Abstract][Full Text] [Related]
2. Evolution of schizophrenia drugs: a focus on dopaminergic systems. Nikam SS; Awasthi AK Curr Opin Investig Drugs; 2008 Jan; 9(1):37-46. PubMed ID: 18183530 [TBL] [Abstract][Full Text] [Related]
3. PDE Inhibitors for the Treatment of Schizophrenia. Snyder GL; Vanover KE Adv Neurobiol; 2017; 17():385-409. PubMed ID: 28956340 [TBL] [Abstract][Full Text] [Related]
4. Aripiprazole, A Drug that Displays Partial Agonism and Functional Selectivity. Tuplin EW; Holahan MR Curr Neuropharmacol; 2017 Nov; 15(8):1192-1207. PubMed ID: 28412910 [TBL] [Abstract][Full Text] [Related]
5. Intracellular signaling and approaches to the treatment of schizophrenia and associated cognitive impairment. Snyder GL; Vanover KE Curr Pharm Des; 2014; 20(31):5093-103. PubMed ID: 24345266 [TBL] [Abstract][Full Text] [Related]
6. Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents. Miyamoto S; Miyake N; Jarskog LF; Fleischhacker WW; Lieberman JA Mol Psychiatry; 2012 Dec; 17(12):1206-27. PubMed ID: 22584864 [TBL] [Abstract][Full Text] [Related]
7. Novel pharmacological approaches to the treatment of schizophrenia. Fink-Jensen A Dan Med Bull; 2000 Jun; 47(3):151-67. PubMed ID: 10913983 [TBL] [Abstract][Full Text] [Related]
8. [Efficacy of atypical antipsychotics in depressive syndromes]. Quintin P; Thomas P Encephale; 2004; 30(6):583-9. PubMed ID: 15738862 [TBL] [Abstract][Full Text] [Related]
9. Atypical antipsychotics: mechanism of action. Seeman P Can J Psychiatry; 2002 Feb; 47(1):27-38. PubMed ID: 11873706 [TBL] [Abstract][Full Text] [Related]
11. Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs. Miyamoto S; Duncan GE; Marx CE; Lieberman JA Mol Psychiatry; 2005 Jan; 10(1):79-104. PubMed ID: 15289815 [TBL] [Abstract][Full Text] [Related]
12. Current use of atypical antipsychotics. Müller-Spahn F Eur Psychiatry; 2002 Aug; 17 Suppl 4():377s-384s. PubMed ID: 23573608 [TBL] [Abstract][Full Text] [Related]
13. The search for novel antipsychotics: pharmacological and molecular targets. Sanger DJ Expert Opin Ther Targets; 2004 Dec; 8(6):631-41. PubMed ID: 15584867 [TBL] [Abstract][Full Text] [Related]
14. Recent developments in the discovery of novel antipsychotic agents modualating dopamine and serotonin receptors. Li X; Ma S Curr Drug Targets; 2013 Jul; 14(8):899-918. PubMed ID: 23701299 [TBL] [Abstract][Full Text] [Related]
15. Aripiprazole: a review of its use in schizophrenia and schizoaffective disorder. Swainston Harrison T; Perry CM Drugs; 2004; 64(15):1715-36. PubMed ID: 15257633 [TBL] [Abstract][Full Text] [Related]
16. Impact of atypical antipsychotics on quality of life in patients with schizophrenia. Awad AG; Voruganti LN CNS Drugs; 2004; 18(13):877-93. PubMed ID: 15521791 [TBL] [Abstract][Full Text] [Related]
17. Upcoming agents for the treatment of schizophrenia: mechanism of action, efficacy and tolerability. Bishara D; Taylor D Drugs; 2008; 68(16):2269-92. PubMed ID: 18973393 [TBL] [Abstract][Full Text] [Related]
18. Building a better antipsychotic: receptor targets for the treatment of multiple symptom dimensions of schizophrenia. Kim DH; Maneen MJ; Stahl SM Neurotherapeutics; 2009 Jan; 6(1):78-85. PubMed ID: 19110200 [TBL] [Abstract][Full Text] [Related]
19. Current Concepts and Treatments of Schizophrenia. Stępnicki P; Kondej M; Kaczor AA Molecules; 2018 Aug; 23(8):. PubMed ID: 30127324 [TBL] [Abstract][Full Text] [Related]
20. [Pathophysiology of schizophrenia and its impact on pharmacotherapy]. Widschwendter CG; Fleischhacker WW Fortschr Neurol Psychiatr; 2005 Nov; 73 Suppl 1():S32-7. PubMed ID: 16270242 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]